SOLIGENIX, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
SOLIGENIX, INC. (SNGX) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$1.54 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2018-03-15
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-12-31 was -$2.65M.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-09-30 was -$176.29K, a 104.36% decline year-over-year.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-06-30 was $525.33K.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2016-03-31 was $760.16K.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2016 was -$1.54M.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2014 was $3.44M.
- SOLIGENIX, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2013 was -$3.65M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$2.83M derived: sum of 2 quarters · filed 2018-03-15 | -$2.30M derived: sum of 3 quarters · filed 2018-03-15 | -$1.54M 10-K · filed 2018-03-15 | $1.54M 10-K · filed 2017-03-27 |
| 2016-09-30 | -$176.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $349.04K derived: sum of 2 quarters · filed 2017-11-06 | $1.11M 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | $525.33K 10-Q · filed 2017-08-11 | $1.29M 10-Q · filed 2017-08-11 | |||
| 2016-03-31 | $760.16K 10-Q · filed 2017-05-11 | ||||
| 2015-09-30 | $4.05M 10-Q · filed 2016-11-10 | ||||
| 2014-12-31 | $3.44M 10-K · filed 2016-03-24 | ||||
| 2014-06-30 | $746.99K 10-Q · filed 2014-08-11 | -$995.10K 10-Q · filed 2014-08-11 | $699.55K derived: sum of 3 quarters · filed 2015-03-25 | -$4.00M derived: sum of 4 quarters · filed 2015-03-25 | |
| 2014-03-31 | -$1.74M 10-Q · filed 2014-05-12 | -$47.44K derived: sum of 2 quarters · filed 2015-03-25 | -$4.75M derived: sum of 3 quarters · filed 2015-03-25 | -$5.40M derived: sum of 4 quarters · filed 2015-03-25 | |
| 2013-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$3.01M derived: sum of 2 quarters · filed 2015-03-25 | -$3.65M derived: sum of 3 quarters · filed 2015-03-25 | -$3.65M 10-K · filed 2015-03-25 | |
| 2013-09-30 | -$4.70M 10-Q · filed 2013-11-12 | -$5.35M derived: sum of 2 quarters · filed 2014-08-11 | -$5.35M 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | -$649.58K 10-Q · filed 2014-08-11 | -$649.58K 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |